The present invention relates to the prediction of antipsychotic treatment efficacy based on a patient's genotype at one or more single nucleotide polymorphism (SNP) loci and to the treatment of a patient based on such prediction.
申请公布号
EP2198049(A1)
申请公布日期
2010.06.23
申请号
EP20080830514
申请日期
2008.09.10
申请人
VANDA PHARMACEUTICALS INC.
发明人
LAVEDAN, CHRISTIAN;VOLPI, SIMONA;LICAMELE, LOUIS;POLYMEROPOULOS, MIHAEL, H.
